Local hormonal treatment for urogenital atrophy after menopause;Traitement hormonal local de l'atrophie urogenitale

Praxis

Volumn 86, Issue 33, 1997, Pages 1245-1248

  Sitruk Ware, R ^a   Thomas, J L ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

estrogens; hypoestrogenism; promestrien; urogenital atrophy; vaginal rings

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; PROMESTRIENE;

ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; POSTMENOPAUSE; REVIEW; UROGENITAL SYSTEM; VAGINA ATROPHY;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGED; ANIMALS; ATROPHY; CLIMACTERIC; ESTRADIOL; ESTRADIOL CONGENERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MIDDLE AGED; UROGENITAL SYSTEM;

EID: 0030810874     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Wright H. J.: The female perspective; women's attitudes towards urogenital ageing. 8th International Congress on the Menopause, Sydney, Australia, (Nov 3-7, 1996). Abstract S29.
2. Samsioe G.: Urogenital Ageing - a hidden problem. 8th International Congress on the Menopause. Sydney, Australia, (Nov 3-7, 1996). Abstract S28.
3. Clarck J. H., Peck E. J. Jr. (1979): Female sex steroids - receptors and function. Monographs on Endocrinology. Springer-Verlag, New York.
4. Schiff I., Tulchinski D., Ryan K. J., Kadner S., Levitz M.: (1980) Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotrophin levels. Am J Obstet Gynecol, 138, 1137-41.
5. Englund D. E., Axelsson OL, Nilsson B. O. (1982): Endometrial effect of vaginal estriol treatment. Acta Obset Gynecol Scand, 106, 23-6.
6. Romanini C., Puparatti L., Finelli F. G. (1986): Local and systemic estrogen activities of two vaginal topical agents used in the treatment of menopausal atrophy. Medicine & Hygiene, 44, 1562-8.
7. Wolff J. P., Cachelou R., Gueritee N. (1982): Lack of hormonal effects of an estradiol diether locally active on the vaginal mucosa. Maturitas, 4, 239-46.
8. Arvis G., Bensadoun R., Lecourt R., Pfeffer H., Sintes G. (1986): Intérêt du promeslriène dans le traitement des troubles mictionnels de la ménopause. Rev Fr Gynecol Obstet, 81, 727-9.
9. Thomas J. L., Mignot A., Roger M., Guillaume M.: Comparison of promestriene (P) absorption by vaginal and oral routes in postmenopausal women. 9th International Congress of Endocrinology. (Aug 30-Sept 5, 1992). Nice France. Abstract no 14.03.047.
10. Palacios S. J., Uribe L., Fernandez Villoria E. (1985): Local and systemic effects after the intravaginal administration of estrogens (Promestrien) in menopausal women. Archives Gynecol, 237, 152 (Abstract 06.11.11).
11. Bonneton A., Dechaud H., Fleury M. C, Colau J C. Pugeat M. (1992): Absence d'influence du promestriène administré par voie vaginale sur le taux circulant des hormones et des protéines hépatiques estrogénodépendanles de la femme ménopausée. Gynécologie, 43 (1), 45-8.
12. Riggl L. A., Milanes B., Villanueva B. (1977): Efficacy of intravaginal and intranasal administration of micronised estradiol 17ß. J. Clin Endocrinol Metab, 45, 1261-4.
13. ACS (1995): Enquête Alain Collomb Stratégies 1995.
14. Lose G., Englev E.: A randomised study to compare lhe efficacy of a vaginal ring (estradiol) with a vaginal pessary (estriol) in postmenopausal women (PMW) with urinary symptoms (US). 8th International Congress on the Menopause, Svdney, Australia, (Nov 3-7 1996). Abstract F141.
15. Devlin C., Gelfan M. M., Nanavati N., Powell M., Steinberg W. M., Wu F., Rioux J. E.: Vagifem™ vs Premarin®, Vaginal cream - a comparative evaluation. 8th International Congress on the Menopause, Sydney, Australia, (Nov 3-7 1996). Abstract F142.
16. Chompootaweep S., Nunthapisud P., Trivijitsilp P., Sentrakul P., Dusitsin N.: The use of two estrogen preparations (a combined contraceptive pill vs conjugated estrogen cream) intravaginally to treat urogenital symtpoms in Thai postmenopausal women: a comparative study, 8th International Congress on the Menopause, Sydney, Australia, (Nov 3-7 1996). Abstract F143.
17. Goebelsmann U., Maschak C. A., Mishell D. R. (1985): Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol, 151, 868-77.